IMMUNIC, INC. — Director's Dealing 2018

Sep 14, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2018-09-12

Reporting Person: Cohen Cheryl (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-09-12	Common Stock	S	3500	$0.55	Disposed	0	Indirect

Footnotes

F1: Shares held by Cheryl L. Cohen Trust U/A 04/01/05 Cheryl L. Cohen Trustee.